Amylyx’s ALS remedy Relyvrio fails PhIII find out about, biotech to believe taking flight drug
Relyvrio, Amylyx’s FDA-approved ALS drug, has failed a crucial Section III trial, the compabig apple stated on Friday, a major blow to what have been considered one of the crucial few significant